Copyright
©The Author(s) 2024.
World J Clin Pediatr. Sep 9, 2024; 13(3): 95010
Published online Sep 9, 2024. doi: 10.5409/wjcp.v13.i3.95010
Published online Sep 9, 2024. doi: 10.5409/wjcp.v13.i3.95010
Characteristics | Conditions |
Family history | ≥ 2 malignancies occurred in family members before the age of 18 years, including the affected child |
First-degree relative (parent or sibling) with cancer < 45 years of age | |
≥ 2 first- or second-degree relatives with cancer in the same parental lineage < 45 years | |
Cancer in consanguineous family | |
Tumor type and/or cancer features known to be strongly associated with cancer predisposition syndrome | |
Adrenocortical carcinoma/adenoma | |
ALL (low hypodiploid) | |
ALL (ring chromosome 21) | |
ALL (Robertsonian translocation 15;21) | |
ALL relapse (TP53 mutated) | |
AML (Monosomy 7) | |
Basal cell carcinoma | |
Botryoid rhabdomyosarcoma of the urogenital tract (fusion-negative) | |
Chondromesenchymal hamartoma | |
Choroid plexus carcinoma/tumor | |
Colorectal carcinoma | |
Cystic nephroma | |
Endolymphatic sack tumor | |
Fetal rhabdomyoma | |
Gastrointestinal stromal tumor | |
Glioma of the optic pathway (with signs of NF1) | |
Gonadoblastoma | |
Hemangioblastoma | |
Hepatoblastoma (CTNNB1 wildtype) | |
Hepatocellular carcinoma | |
Infantile myofibromatosis | |
Juvenile myelomonocytic leukemia | |
Keratocystic odontogenic tumor | |
Large cell calcifying Sertoli-cell-tumor | |
Malignant peripheral nerve sheath tumor | |
Medullary thyroid carcinoma | |
Medulloblastoma (SHH activated) | |
Medulloblastoma (WNT activated, CTNNB1 wildtype) | |
Medullary renal cell carcinoma | |
Medulloepithelioma | |
Melanoma | |
Meningioma | |
Myelodysplastic syndrome | |
Myeloproliferative neoplasms (except CML) | |
Myxoma | |
Neuroendocrine tumor | |
Paraganglioma/pheochromocytoma | |
Parathyroid carcinoma/adenoma | |
Pineoblastoma | |
Pituitary adenoma/tumor | |
Pituitary blastoma | |
Pleuropulmonary blastoma | |
Renal cell carcinoma | |
Retinoblastoma | |
Rhabdoid tumor | |
Rhabdomyosarcoma with diffuse anaplasia | |
Schwannoma | |
Schwannomatosis | |
Sertoli-Leydig cell tumor | |
Sex cord-stromal tumor with annular tubules | |
Small-cell carcinoma of the ovary, hypercalcemic type | |
Squamous cell carcinoma | |
Subependymal giant cell astrocytoma | |
Thyroid carcinoma (non-medullary) | |
Transient myeloproliferative disease | |
Other rare cancers or cancers that typically occur in adults, unusually early manifestation age | |
Genetic tumor analysis reveals a defect suggesting germline cancer predisposition | |
A child with ≥ 2 malignancies (secondary, bilateral in paired organs, multifocal, synchronous, or metachronous) | |
A child with cancer and obvious nonmalignant signs suggestive of a genetic condition | Congenital anomalies |
Facial dysmorphism | |
Mental impairment, developmental delay | |
Abnormal growth | |
Skin anomalies (abnormal pigmentation, i.e. ≥ 2 café-au-lait spots, vascular lesions, hypersensitivity to sunlight, benign tumors) | |
Immune deficiency | |
Endocrine anomalies | |
A child with excessive treatment toxicity |
- Citation: Roganovic J. Genetic predisposition to childhood cancer. World J Clin Pediatr 2024; 13(3): 95010
- URL: https://www.wjgnet.com/2219-2808/full/v13/i3/95010.htm
- DOI: https://dx.doi.org/10.5409/wjcp.v13.i3.95010